Clinical pharmacology of antiarrhythmic agents.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000813:Anilides / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000503:physiopathology; D044482:Benzeneacetamides; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004594:Electrophysiology; D016700:Encainide; D005424:Flecainide; D006329:Heart Conduction System / Q000502:physiology; D006801:Humans; D008012:Lidocaine / Q000031:analogs & derivatives / Q000627:therapeutic use; D016293:Moricizine; D010640:Phenothiazines / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D013015:Sotalol / Q000627:therapeutic use; D016677:Tocainide
D000319:Adrenergic beta-Antagonists; D000813:Anilides; D000889:Anti-Arrhythmia Agents; D044482:Benzeneacetamides; D002121:Calcium Channel Blockers; D010640:Phenothiazines; D010880:Piperidines; D000644:Quaternary Ammonium Compounds; D016677:Tocainide; D016293:Moricizine; C022799:clofilium; D008012:Lidocaine; D013015:Sotalol; D005424:Flecainide; C015970:lorcainide; D016700:Encainide